However, as mentioned above, the pathogenesis of C9orf72-associated ALS/FTD involves multiple pathways, and these small molecule compounds only play a role in a single pathway, thereby limiting its therapeutic effects. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.